VITR Share Price Performance
SEK 0
-134.60 (-100.00%)
Price SEK 0
Fair ValueSEK 130.20
Share Pricen/a
Narrative Update • Aug 12
Vitrolife AB (publ) Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
VITR Community Narratives
AN
Fair Value
·Fair Value SEK 130.2 30.0% undervalued intrinsic discount
Profit Margins And Revenue Outlook Will Support Recovery Trends Ahead
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value
·Fair Value SEK 95 4.1% undervalued intrinsic discount
IVF Cycle Recovery And Consumables Momentum Will Support A Fairly Valued Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value SEK 155 41.2% undervalued intrinsic discount
IVF Technology Adoption And Genetic Testing Demand Will Drive Strong Long-Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Vitrolife
41.2% undervalued intrinsic discount
IVF Technology Adoption And Genetic Testing Demand Will Drive Strong Long-Term Upside
View narrativeAN
Updated 12 Aug
Vitrolife
30.0% undervalued intrinsic discount
Profit Margins And Revenue Outlook Will Support Recovery Trends Ahead
View narrativeAN
Updated 14 Jul
Vitrolife
4.1% undervalued intrinsic discount
IVF Cycle Recovery And Consumables Momentum Will Support A Fairly Valued Outlook
View narrativeAN
Updated 28 Jul
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
VITR: CEO Transition And Higher Margin Outlook Will Support Future Upside
Fair Value: SEK 155 41.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
VITR: Leadership Transition And Revised Outlook Will Shape Fairly Balanced Prospects
Fair Value: SEK 95 4.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
VITR: Leadership Transition And Bearish Research Will Set Up Future Re-Rating Potential
Fair Value: SEK 130.2 30.0% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Vitrolife AB (publ) Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 22, 2026
- -36.80
- 59.23%
- -146.99%
- 18.1%
About VITR
- Founded
- 1989
- Employees
- 1103
- CEO
- WebsiteView website
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
Recent VITR News & Updates
Narrative Update • Jul 28
